Sage Journals: Discover world-class research

Open access

Research article

First published 2022

Comprehensive analysis of MET mutations in NSCLC patients in a real-world setting

Xinghao Ai, Yongfeng Yu, Jun Zhao [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2008-06

HGF and MET Mutations in Primary and Secondary Lymphedema

David N. Finegold, Vivien Schacht, Mark A. Kimak [...]

Lymphatic Research and Biology

Retricted access

Research article

First published 2001-06

Papillary Renal Cell Carcinoma: Analysis of Germline Mutations in the MET Proto-Oncogene in a Clinic-Based Population

Noralane M. Lindor, Christopher B. Dechet, Mark H. Greene [...]

Genetic Testing and Molecular Biomarkers

Retricted access

Case report

First published 2020-3

An advanced c-MET-amplified NSCLC patient that was treated with crizotinib

Mesut Yilmaz, Sermin Guven Mese, Ibrahim Cil [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2024

Assessment of efficacy and safety of MET tyrosine kinase inhibitors in non-small-cell lung cancer patients with MET alterations

Yanhua Wang, Manyi Xu, Ke Wang [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2019

The Relationship Between IDH1 Mutation Status and Metabolic Imaging in Nonenhancing Supratentorial Diffuse Gliomas: A 11 C-MET PET Study

Nijiati Kudulaiti, Huiwei Zhang, Tianming Qiu [...]

Molecular Imaging

Open access

Case report

First published 2022

Treatment Response to Immunotherapy After Crizotinib Resistance in a Patient With Pulmonary Sarcomatoid Carcinoma Harboring MET Exon 14 Skipping Mutation: A Case Report

Ling Gu, Xiaoying Wei, Zixiang Zhang [...]

Clinical Medicine Insights: Oncology

Open access

Research article

First published 2024

Molecular features and clinical outcomes of EGFR-mutated,MET-amplified non-small-cell lung cancer after resistance to dual-targeted therapy

Mei-Mei Fang, Jiang-Tao Cheng, Yu-Qing Chen [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022

Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program

Oliver Illini, Hannah Fabikan, Aurélie Swalduz [...]

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2023-1

Pulmonary embolism and bradycardia in a NSCLC patient treated with crizotinib for a rare mutation

Yunjing Shi, Zeping Qiu, Yongjie Ding [...]

Journal of Oncology Pharmacy Practice

Search results